Answers are grounded in this paper and cite their sources.
We aimed to evaluate the drug coated balloon (DCB) based on lightweight deep learning model on coronary bifurcation lesions in patients with coronary artery disease (CAD). A lightweight deep learning model was applied to coronary angiography in patients. According to the different use of balloon after pre-treatment of branch vessel cutting balloon, the patients were assigned to observation (n = 45) and control (n = 45) groups. In terms of demographic data, no significant difference was observed between the groups (P >0·05). Similarly, no intergroup difference of statistical significance was found in Medina classification, reference diameter and minimum diameter of main branches (P >0·05). Following a 9-month period of follow-up, a significantly lower rate of adverse reaction (4.44%) was observed in the observation group, as opposed to the control group (17.78%) (P <0·05). While there was a postoperative decrease in the extent of vascular stenosis in both groups, the extent to which vascular stenosis was reduced in the observation group was markedly higher (P <0·05). In the results of branch re-examination diameter confirmed an intergroup difference of statistical significance (P <0·05). The duration of exposure to X-rat, operation time, and average dosage of contrast agent was substantially lower in the observation group (P <0·05). DCB active protection technology can reduce the extent of vascular stenosis in CAD.
No takes yet. Share an insight, caveat, or question.
Li et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: